NIPH Clinical Trials Search

Basic Information

Recruitment status	recruiting
Health condition(s) or Problem(s) studied
Date of first enrollment	30/03/2020
Target sample size	30
Countries of recruitment	Japan,Asia except Japan,North America,null
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : Mirikizumab Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	pharmacokinetics
Secondary Outcome	safety efficacy confirmatory exploratory pharmacokinetics pharmacodynamics

Key inclusion & exclusion criteria

Age minimum	>= 2age old
Age maximum	<= 17age old
Gender	Both
Include criteria
Exclude criteria